Strategic Acquisition Drives XTL Biopharmaceuticals (XTLB) To Nearly Double
Fahim Awan
March 20, 2024
During the current trading session, the shares of XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) are experiencing a notable surge of 98.06%, culminating in a valuation of